BFM
VERA icon

Boothbay Fund Management’s Vera Therapeutics VERA Stock Holding History

Boothbay Fund Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$901K Hold
21,000
– – 0.01% 1159
2026
Q1 		$845K Buy
+21,000
New +$905K 0.01% 1030
2025
Q3 		– Sell
-54,700
Closed -$1.29M – 2194
2025
Q2 		$1.29M Buy
+54,700
New +$1.23M 0.03% 607

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boothbay Fund Management's VERA Position: Q2 2026 in Review

Boothbay Fund Management increased its Vera Therapeutics (VERA) stake by 56% in Q2 2026, buying an estimated $1.35M and bringing the position to 100,966 shares worth $4.33M. The position accounts for 0.06% of the portfolio, ranked #396.

Boothbay Fund Management first reported a position in VERA in Q4 2024 and has held it in 7 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Boothbay Fund Management held 100,966 shares of Vera Therapeutics worth $4.33M as of Q2 2026.
  • Boothbay Fund Management bought 36,288 Vera Therapeutics shares in Q2 2026, an estimated $1.35M.
  • Vera Therapeutics made up 0.06% of Boothbay Fund Management's portfolio in Q2 2026, its #396 holding.
  • Boothbay Fund Management first reported a position in Vera Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.